PL1989544T3 - Testy na komórkach T - Google Patents

Testy na komórkach T

Info

Publication number
PL1989544T3
PL1989544T3 PL07712817T PL07712817T PL1989544T3 PL 1989544 T3 PL1989544 T3 PL 1989544T3 PL 07712817 T PL07712817 T PL 07712817T PL 07712817 T PL07712817 T PL 07712817T PL 1989544 T3 PL1989544 T3 PL 1989544T3
Authority
PL
Poland
Prior art keywords
cell responses
cell assays
cell
novel
antigens
Prior art date
Application number
PL07712817T
Other languages
English (en)
Inventor
Mathew Baker
Francis J Carr
Alyson Rust
Laura Davies
Original Assignee
Antitope Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0604170A external-priority patent/GB0604170D0/en
Priority claimed from GB0619374A external-priority patent/GB0619374D0/en
Priority claimed from GB0620123A external-priority patent/GB0620123D0/en
Application filed by Antitope Ltd filed Critical Antitope Ltd
Publication of PL1989544T3 publication Critical patent/PL1989544T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517CD8
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
PL07712817T 2006-03-02 2007-03-02 Testy na komórkach T PL1989544T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0604170A GB0604170D0 (en) 2006-03-02 2006-03-02 T cell assays
GB0619374A GB0619374D0 (en) 2006-09-29 2006-09-29 T cell asays
GB0620123A GB0620123D0 (en) 2006-10-11 2006-10-11 T cell assays
PCT/GB2007/000736 WO2007099341A1 (en) 2006-03-02 2007-03-02 T cell assays
EP07712817A EP1989544B1 (en) 2006-03-02 2007-03-02 T cell assays

Publications (1)

Publication Number Publication Date
PL1989544T3 true PL1989544T3 (pl) 2012-01-31

Family

ID=38191208

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07712817T PL1989544T3 (pl) 2006-03-02 2007-03-02 Testy na komórkach T

Country Status (14)

Country Link
US (1) US20090221024A1 (pl)
EP (1) EP1989544B1 (pl)
JP (1) JP5161798B2 (pl)
KR (1) KR101361887B1 (pl)
AT (1) ATE514081T1 (pl)
AU (1) AU2007220300A1 (pl)
CA (1) CA2644540C (pl)
DK (1) DK1989544T3 (pl)
HK (1) HK1126274A1 (pl)
PL (1) PL1989544T3 (pl)
PT (1) PT1989544E (pl)
RU (1) RU2476884C2 (pl)
SG (1) SG170051A1 (pl)
WO (1) WO2007099341A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE20090514A1 (en) 2009-07-06 2011-02-16 Opsona Therapeutics Ltd Humanised antibodies and uses therof
JPWO2011027810A1 (ja) * 2009-09-03 2013-02-04 独立行政法人理化学研究所 アレルゲン特異的リンパ球の検出方法
EP2475383A4 (en) 2009-09-06 2013-07-17 Protab Ltd FOR THE PEPTIDE PRODUCED FROM HSP65 6 SPECIFIC HUMANIZED ANTIBODIES AND USES THEREOF
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
WO2013119947A1 (en) 2012-02-09 2013-08-15 Baylor College Of Medicine Pepmixes to generate multiviral ctls with broad specificity
RU2681994C2 (ru) 2012-12-26 2019-03-14 Онкосинерджи, Инк. КОМПОЗИЦИИ АНТИТЕЛА К ИНТЕГРИНУ β1 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
WO2014180490A1 (en) * 2013-05-10 2014-11-13 Biontech Ag Predicting immunogenicity of t cell epitopes
IL258090B2 (en) 2015-09-18 2023-04-01 Baylor College Medicine Immunogenic detection of antigen from a pathogen and adjustment of effective clinical treatment
JP7369524B2 (ja) * 2016-12-27 2023-10-26 中外製薬株式会社 被験物質の免疫原性を評価する方法
RU2722648C2 (ru) * 2018-11-16 2020-06-02 федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Способ проверки иммуногенности вакцинных антигенов для получения высокоэффективных вакцин против опасных инфекций

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2252643A1 (en) * 1996-04-23 1997-10-30 President And Fellows Of Harvard College Methods and compositions for regulating t cell subsets by modulating transcription factor activity
WO1999019484A1 (en) * 1997-10-10 1999-04-22 Basf Aktiengesellschaft T cell receptor-associated molecules (trams) and methods of use therefor
US7112324B1 (en) * 1998-04-21 2006-09-26 Micromet Ag CD 19×CD3 specific polypeptides and uses thereof
EP1241249A1 (en) * 2001-03-12 2002-09-18 Gerold Schuler CD4+CD25+regulatory T cells from human blood
ATE467421T1 (de) * 2002-05-01 2010-05-15 Danisco Us Inc Cytokine und cytokinrezeptoren mit reduzierter immunogenität
NZ537816A (en) * 2002-08-08 2007-06-29 Baylor College Medicine An autologous T cell vaccine for the treatment of multiple sclerosis
AU2003285586A1 (en) * 2002-12-03 2004-06-23 Medical Research Council Regulatory t-cells

Also Published As

Publication number Publication date
EP1989544B1 (en) 2011-06-22
AU2007220300A1 (en) 2007-09-07
HK1126274A1 (en) 2009-08-28
PT1989544E (pt) 2011-09-26
WO2007099341A1 (en) 2007-09-07
RU2476884C2 (ru) 2013-02-27
DK1989544T3 (da) 2011-09-26
CA2644540C (en) 2014-09-30
JP5161798B2 (ja) 2013-03-13
JP2009528044A (ja) 2009-08-06
EP1989544A1 (en) 2008-11-12
ATE514081T1 (de) 2011-07-15
US20090221024A1 (en) 2009-09-03
SG170051A1 (en) 2011-04-29
KR101361887B1 (ko) 2014-02-21
KR20080109008A (ko) 2008-12-16
RU2008136561A (ru) 2010-04-10
CA2644540A1 (en) 2007-09-07

Similar Documents

Publication Publication Date Title
HK1126274A1 (en) T cell assays t
WO2013074520A3 (en) Detection, isolation and analysis of rare cells in biological fluids
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
EP4249605A3 (en) Methods for analyte detection
BR112012016119B1 (pt) método de detecção de células em uma amostra, dispositivo unitário de preparação e detecção de amostra e kit
BR112015014833A2 (pt) anticorpo isolado ou fragmento de ligação de antígeno deste, ácido nucléico isolado, célula hospedeira, método de ensaiar uma amostra de tecido removido de um humano para expressão de pd-l1, estojo, e, composição de anticorpo que compreende uma mistura de moléculas do anticorpo
AR053948A1 (es) Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente
EA200971124A1 (ru) Множественный анализ образцов крови
NZ609824A (en) Immunochromatography devices, methods and kits
WO2005075986A3 (en) Method and kit for the measurement of neutrophil cell activation
BR112014020512A8 (pt) Métodos e sistemas para a detecção de microorganismos
WO2007114986A3 (en) Cooperative probes and methods of using them
EP3851856A3 (en) Method, array and use thereof
EA201370070A1 (ru) СПОСОБ ДЕТЕКЦИИ, ДИФФЕРЕНЦИАЦИИ И КВАНТИФИКАЦИИ ПОПУЛЯЦИЙ Т-КЛЕТОК С ИСПОЛЬЗОВАНИЕМ КОЛИЧЕСТВЕННОЙ ПЦР С ОБРАТНОЙ ТРАНСКРИПЦИЕЙ В РЕАЛЬНОМ ВРЕМЕНИ (ОТ-колПЦР РВ)
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
WO2011109326A3 (en) Crosslinking reagents, methods, and compositions for studying protein-protein interactions
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
WO2015035239A3 (en) Reagents and methods for screening mps i, ii, iiia, iiib, iva, vi, and vii
EP2577307A4 (en) DIAGNOSTIC TEST
MX2009010751A (es) Composiciones y metodos de deteccion.
ATE489632T1 (de) Antigennachweis
NZ590219A (en) Sample carrier for effecting chemical assays with mixing and detecting zone separated by a pathway with inlet.
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
RU2009128762A (ru) Способ и набор для иммуноферментного определения функциональной активности компонента с3 комплемента человека
WO2011113813A3 (en) Assay for analytes based on aggregation